156 related articles for article (PubMed ID: 38270686)
21. Improved intratumoral penetration of radiolabeled streptavidin in intraperitoneal tumors pretargeted with biotinylated antibody.
Zhang M; Yao Z; Saga T; Sakahara H; Nakamoto Y; Sato N; Nakada H; Yamashina I; Konishi J
J Nucl Med; 1998 Jan; 39(1):30-3. PubMed ID: 9443734
[TBL] [Abstract][Full Text] [Related]
22. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice.
Chanda N; Kan P; Watkinson LD; Shukla R; Zambre A; Carmack TL; Engelbrecht H; Lever JR; Katti K; Fent GM; Casteel SW; Smith CJ; Miller WH; Jurisson S; Boote E; Robertson JD; Cutler C; Dobrovolskaia M; Kannan R; Katti KV
Nanomedicine; 2010 Apr; 6(2):201-9. PubMed ID: 19914401
[TBL] [Abstract][Full Text] [Related]
23. Direct intratumoral infusion of liposome encapsulated rhenium radionuclides for cancer therapy: effects of nonuniform intratumoral dose distribution.
Hrycushko BA; Li S; Goins B; Otto RA; Bao A
Med Phys; 2011 Mar; 38(3):1339-47. PubMed ID: 21520844
[TBL] [Abstract][Full Text] [Related]
24. Diabody Pretargeting with Click Chemistry In Vivo.
van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
[TBL] [Abstract][Full Text] [Related]
25. Comparison of
Safigholi H; Meigooni AS; Song WY
Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
[TBL] [Abstract][Full Text] [Related]
26. Gum arabic-coated radioactive gold nanoparticles cause no short-term local or systemic toxicity in the clinically relevant canine model of prostate cancer.
Axiak-Bechtel SM; Upendran A; Lattimer JC; Kelsey J; Cutler CS; Selting KA; Bryan JN; Henry CJ; Boote E; Tate DJ; Bryan ME; Katti KV; Kannan R
Int J Nanomedicine; 2014; 9():5001-11. PubMed ID: 25378926
[TBL] [Abstract][Full Text] [Related]
27.
Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
[TBL] [Abstract][Full Text] [Related]
28. Imageable Brachytherapy with Chelator-Free Radiolabeling Hydrogel.
Cui Z; Wang L; Liu W; Xu D; Zhang T; Ma B; Zhang K; Yuan L; Bing Z; Liu J; Liu B; Wu W; Tian L
Adv Healthc Mater; 2024 May; ():e2401438. PubMed ID: 38744050
[TBL] [Abstract][Full Text] [Related]
29. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
30. Phthalocyanine-Conjugated Upconversion NaYF
Kostiv U; Patsula V; Noculak A; Podhorodecki A; Větvička D; Poučková P; Sedláková Z; Horák D
ChemMedChem; 2017 Dec; 12(24):2066-2073. PubMed ID: 29105372
[TBL] [Abstract][Full Text] [Related]
31. [Experimental study of CT guided ³²P-CP-PLLA microparticle implantation in the treatment of rabbit VX2 lung tumor].
Pan D; Yang M; Xu Y; Wang L; Liu L; Huang P
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):1-6. PubMed ID: 21219823
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers.
Xu J; Cai F; Luo Z; Fan W; Dai J; Cui J; Li S; Geng C; Zheng Q; Wang Z; Tang X
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2618-2633. PubMed ID: 35347438
[TBL] [Abstract][Full Text] [Related]
33. Development of Dendrimer Encapsulated Radio-Ytterbium and Biodistributionin Tumor Bearing Mice.
Aghaei-Amirkhizi N; Moghaddam-Banaem L; Athari-Allaf M; Sadjadi S; Johari-Daha F
IEEE Trans Nanobioscience; 2016 Sep; 15(6):549-554. PubMed ID: 27824577
[TBL] [Abstract][Full Text] [Related]
34. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
Morcos M; Viswanathan AN; Enger SA
Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739
[TBL] [Abstract][Full Text] [Related]
35. MicroPET-CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts.
Jian L; Zhongmin W; Kemin C; Yunfeng Z; Gang H
Acta Radiol; 2013 Sep; 54(7):800-4. PubMed ID: 23612430
[TBL] [Abstract][Full Text] [Related]
36. A dosimetric model for the heterogeneous delivery of radioactive nanoparticles In vivo: a feasibility study.
Satterlee AB; Attayek P; Midkiff B; Huang L
Radiat Oncol; 2017 Mar; 12(1):54. PubMed ID: 28302144
[TBL] [Abstract][Full Text] [Related]
37. Investigation the effect of a magnetic field on the dose distribution of I-125, Ir-192, Yb-169, and Co-60 brachytherapy sources by Monte Carlo simulation.
Jafarzadeh N; Hejazi P; Tajik Mansoury MA; Khodabakhshi R; Riazi Z; Gholami S
Appl Radiat Isot; 2022 Sep; 187():110332. PubMed ID: 35717903
[TBL] [Abstract][Full Text] [Related]
38. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
[TBL] [Abstract][Full Text] [Related]
39. Validation study of ¹³¹I-RRL: assessment of biodistribution, SPECT imaging and radiation dosimetry in mice.
Zhao Q; Yan P; Yin L; Li L; Chen XQ; Ma C; Wang RF
Mol Med Rep; 2013 Apr; 7(4):1355-60. PubMed ID: 23440460
[TBL] [Abstract][Full Text] [Related]
40. Local control of lung derived tumors by diffusing alpha-emitting atoms released from intratumoral wires loaded with radium-224.
Cooks T; Schmidt M; Bittan H; Lazarov E; Arazi L; Kelson I; Keisari Y
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):966-73. PubMed ID: 19480976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
